Trusted Resources: Education
Scientific literature and patient education texts
Mucopolysaccharidosis Patients Have Reduced Functional Capacity
source: Pediatric pulmonology
year: 2022
authors: Dias BMC,Lanza FC,Santos JD,Aranda CS,Solé D,Martins AM,Wandalsen GF
summary/abstract:Mucopolysaccharidoses (MPSs) are a group of rare diseases caused by an intralysosomal accumulation of glycosaminoglycans, resulting in a multisystemic clinical condition characterized by variable degrees of physical-functional impairment.
organization: Universidade Federal de São Paulo (EPM-UNIFESP), São Paulo, São Paulo, Brazil.DOI: 10.1002/ppul.25750
read more
BookmarkRelated Content
-
Glycosaminoglycans As Biomarkers for Mucopolysaccharidoses and Other DisordersGlycosaminoglycans (GAGs) are present in...
-
Mucopolysaccharidoses Diagnosis in the Era of Enzyme Replacement Therapy in EgyptUndegraded glycosaminoglycans (GAGs) ind...
-
Mucopolysaccharidosis Type 1 (MPS 1)What is Mucopolysaccharidosis Type 1?Muc...
-
Secondary Ganglioside GM2 Accumulation in MucopolysaccharidosesIn vivo, the lysosomal degradation of GM...
-
CHOC-Harbor UCLA MPS Multidisciplinary CenterCHOC and Harbor-UCLA Pediatrics together...
-
Extraordinary Experiences ProgramProgram provides grants of up to $1000 t...
-
Daily Living With MPS and Related DiseasesDealing with your child’s diagnosis wi...
Powered by
